<DOC>
	<DOCNO>NCT00419705</DOCNO>
	<brief_summary>The purpose pivotal study demonstrate safety effectiveness NeuroThera® Laser System ( refer hereafter NTS ) treatment Subjects diagnose acute ischemic stroke . The initiation NTS treatment must feasible Subject within 24 hour stroke onset .</brief_summary>
	<brief_title>Effectiveness Safety Trial New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset ( NEST-2 )</brief_title>
	<detailed_description>This study prospective , double blind , randomize , sham control , parallel group , multi-center study include enrollment 660 Subjects . Subjects follow 90 day post stroke onset . The primary effectiveness endpoint study binary endpoint defines success modify Rankin Scale ( mRS ) score 0-2 failure mRS score 3-6 90 day last rating . The secondary effectiveness endpoint study change NIHSS score baseline 90 day last rating , analyze across full range score NIHSS . Tertiary effectiveness endpoint include : The 90-day binary endpoint , denote 90-day bNIH score , base NIHSS score defines successful result either ( ) improvement 9 point NIHSS ( ii ) final NIHSS score 0 1 ; score mRS 90 day last rating analyze across range score 0 6 mRS scale , SIS-16 90 day ; mortality 30 , 60 90 day .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>1 . Diagnosis Acute Ischemic Stroke within 24 hour 2 . Clinical diagnosis Acute Ischemic Stroke exclusion hemorrhage CT scan susceptibility weight MRI sequence 3 . NIHSS ≥7 ≤22 1 . &gt; 24hours symptom onset time treatment 2 . Evidence intracranial , subdural , subarachnoid hemorrhage 3 . Clinical presentation intracranial hemorrhage 4 . Pre stroke ≥3 mRS 5 . The presence brainstem cerebellar stroke 6 . Transient Ischemic Attack ( TIA ) 7 . Seizure stroke onset 8 . Blood glucose &gt; 400 &lt; 60 9 . Sustained systolic BP &gt; 220mmHG &lt; 80mmHG diastolic &gt; 140mmHG &lt; 50mmHG 10 . Septic embolus 11 . CNS tumor ( except asymptomatic meningioma ) 12 . Dermatologic condition scalp ( e.g . Psoriasis ) 13 . Thrombolytic therapy 14 . Head implant ( e.g . Clipped aneurysm , Hakim valve )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>acute stroke</keyword>
	<keyword>infrared laser therapy</keyword>
	<keyword>clinical trial</keyword>
	<keyword>safety</keyword>
	<keyword>effectiveness</keyword>
</DOC>